UNSPSC 85543012: Restriction of thorax lymphatic with extraluminal device, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to restriction of thorax lymphatic with extraluminal device, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 07V73CZ

UNSPSC 85543012 Restriction of thorax lymphatic with extraluminal device, percutaneous approach is a Commodity code that the source material does not align with actual state and local procurement activity. The code's nominal clinical scope—a specific surgical procedure involving thorax lymphatic restriction—does not correspond to the medical and health services state and local governments are actually buying under this tag. The recent opportunities posted against this code cover independent medical evaluation services for disability determinations, occupational medical surveillance programs, surgical benefit carve-out management for employee health plans, pharmacy benefit administration, temporary health professional staffing, emergency medical services for detained youth, and related administrative healthcare contracting. None of these solicitations involve the procedural intervention the code nominally describes.

The mismatch suggests either miscoding in the source data or that this code has been applied categorically to health-services procurement that spans well beyond a single procedure type. State and local buying entities issuing under this code include Arizona municipalities and pension boards (City of Phoenix), California coastal cities (City of Long Beach), Washington state transportation authorities (WSDOT), county health systems (Santa Clara County Health System, Harris County), and county human resources and benefits administration offices (Collier County). The geographic spread spans Arizona, California, Washington, Florida, and Texas. Without opportunities that actually reflect the code's stated clinical scope, the code shows little actionable signal for vendors targeting procedures or devices in the thorax lymphatic space.